malayamycin A: from Streptomyces malaysiensis; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 9819404 |
| MeSH ID | M0477442 |
| Synonym |
|---|
| malayamycin a |
| [(2s,3s,3as,6s,7r,7ar)-2-(2,4-dioxo-1h-pyrimidin-5-yl)-3-hydroxy-6-methoxy-3,3a,5,6,7,7a-hexahydro-2h-furo[3,2-b]pyran-7-yl]urea |
Malayamycin A is an unusual bicyclic C-nucleoside. It has interesting antiviral, antifungal, and anticancer bioactivity.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Malayamycin A is an unusual bicyclic C-nucleoside, with interesting antiviral, antifungal, and anticancer bioactivity. " | ( C-Nucleoside Formation in the Biosynthesis of the Antifungal Malayamycin A. Hong, H; Leadlay, PF; Samborskyy, M; Zhou, Y, 2019) | 2.2 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.26) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||